Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor über 5 Jahren |
| Titel | Datum |
|---|---|
| Duopharma, IGB, MISC, Seal, GDB, Johan Holdings & Farmiera | vor 30 Tagen |
| MISC, PTSC Extend Ruby II FPSO Operations Offshore Vietnam | vor 30 Tagen |
| MISC secures FPSO Ruby II contract extension in Vietnam until end-2027 | vor 30 Tagen |
| BHIC, Petron Malaysia, Hartalega, Hong Leong Industries, Sam Engineering, Tomei, Teo Seng, CelcomDigi, Axiata, Iskandar Waterfront, Exsim... | vor ungefähr einem Monat |
| MISC wins 15-year ExxonMobil PNG FSO charter to launch first PNG offshore unit | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |